Scientists from New York University Abu Dhabi (UAE) have developed a new microfluidic platform compatible with atomic force microscopy that could be used to perform liquid cancer biopsies. The tool could also be used to identify new metastatic mechano-biomarkers.
As part of our feature examining lab-on-a-chip technology, we interviewed lab-on-a-chip expert, Aaron Wheeler from the University of Toronto (Canada). Aaron described his experience and research in the field and explained to us that the age of lab-on-a-chip is upon us.
Through the integration of the latest nanotechnology and bioengineering, scientists have begun to develop a wide range of microfluidic chips. Check out this list to explore some of the most exciting recently developed devices.
Researchers based at the University of Toronto (ON, CA) have developed a microfluidic device that could be used to separate malignant plasma cells from healthy red blood cells. The device could have the potential to detect and monitor blood cancer.
A novel microarray has been developed by researchers that incorporates both physical and electrostatic features to improve diagnostic methods for cervical cancer.
Researchers have developed a new chip device that offers superior forensic blood residue detection compared to current methods such as the use of luminol.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.
Researchers have developed an organ-on-a-chip that could aid the understanding of premature births as it replicates the functions of the placenta membrane.
A low cost and portable smartphone integrated system could improve infectious disease treatment and allow for better surveillance.
Researchers have developed a tiny microfluidic device capable of incubating cancer cells for long enough to investigate the intricate details of metastatic characteristics.